Lifebit’s Platform offers researchers and clinicians a data-driven view into the determinants of health and disease, facilitating clinical impacts and accelerating drug discovery.
Health data comes from a wide range of sources, including biobanks, clinical trials and electronic health records. With this diversity comes wide variability in how data is described and stored, which creates challenges for researchers preparing data for analyses.
Key challenges:
Common Data Models are being increasingly adopted across the healthcare industry to address the lack of data standardisation. Having datasets standardised to a consistent and accessible format means they can be easily merged and analysed for research.
Fully integrated within Lifebit’s Platform, the Data Transformation Suite is a flexible set of pipelines that transform raw data to analysis-ready data using the OMOP Common Data Model.
Benefits:
Find out how top 20 pharmaceutical companies are using Lifebit’s Data Transformation Suite to capture the transformational value of biobank data and prepare their data for research at scale.